ProducsProprietary Products

KamRAB

Therapeutic indication:

KamRAB is indicated for passive, transient post-exposure prevention of rabies infection when given immediately to individuals in cases of contact with rabid or possibly rabid animal.

  • Composition: Human-rabies immunoglobulin 150 IU/ml
  • Pharmaceutical form: Solution for injection
  • Method of administration: intramuscular
  • Manufacturer: Kamada